Anderson, S., Karlstaedt, A., Young, M., Karatzia, L., Cullen, F., Chen, J., O’Riordan, C. E., Barnes, M. R., Štaka, Z., Albee, L. J., Garrod-Ketchley, C., Dambure, S., Prag, H. A., Cvetko, F.
, Miller, J. J. J. J., Thiemermann, C., Lewis, A. J. M., Murphy, M. P., Smith, D. M. ... Aksentijevic, D. (2026).
Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy.
Nature Cardiovascular Research,
5(2), 138-154.
https://doi.org/10.1038/s44161-025-00769-0